Home > Products > CD317 & CD16 > Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (scDiabody-CH3)

Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (scDiabody-CH3)  (CAT#: SCDBC-111)

Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (scDiabody-CH3) is a fusion protein of two scDiabodies connected together by a CH3 region. In single-chain Diabodies, an additional connecting linker is introduced between chains of the anti-CD317/anti-CD16 diabody. The scDiabody with two specificities is fused to each of the CH3 chains to extend half-life. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Multiple myeloma (MM) therapy.
Datasheet INQUIRY

Specifications

Targets
CD317 & CD16
Type
Constant Domain-extended Bispecific Fragments
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Multiple myeloma (MM)

Targets

Target 1
CD317
Gene ID
UniProt ID
Alternative Names
CD317; TETHERIN; BST2; bone marrow stromal cell antigen 2; Cluster of differentiation 317
Target 2
CD16
Gene ID
UniProt ID
Alternative Names
FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); CD16; FCG3; CD16A; FCGR3; IGFR3; IMD20; FCR-10; FCRIII; FCGRIII; FCRIIIA; low affinity immunoglobulin gamma Fc region receptor III-A; FcγRIII; FcgammaRIIIA; CD16a antigen; fc-gamma RIII; Fc-gamma RIIIa; Fc-gamma RIII-alpha; igG Fc receptor III-2; Fc gamma receptor III-A; Fc-gamma receptor IIIb (CD16); neutrophil-specific antigen NA; Fc-gamma receptor III-2 (CD 16); immunoglobulin G Fc receptor III; Fc fragment of IgG, low affinity III, receptor for (CD16)
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD317 & CD16"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD317 x Anti-CD16 Bispecific Antibody (scDiabody-CH3) (SCDBC-111). Click the button below to contact us or submit your feedback about this product.